Human medicines European public assessment report (EPAR): Nulojix, belatacept, Date of authorisation: 17/06/2011, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Brineura, cerliponase alfa, Date of authorisation: 30/05/2017, Revision: 7, Status: Authorised

Data Analysis and Real World Interrogation Network (DARWIN EU)

DARWIN EU Advisory Board meeting - 24 May 2023, European Medicines Agency, Amsterdam, the Netherlands, from 24 May 2023, 14:30 (CEST) to 24 May 2023, 16:30 (CEST)

Academia Info Day, European Medicines Agency, Amsterdam, the Netherlands, from 10 November 2023, 09:30 (CET) to 10 November 2023, 13:30 (CET)

DARWIN EU Advisory Board meeting: 6 February 2023, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 February 2023, 10:00 (CET) to 6 February 2023, 12:00 (CET)

Clinical Trials Information System (CTIS): Walk-in clinic - November 2023, Online, European Medicines Agency, Amsterdam, the Netherlands, from 15 November 2023, 16:00 (CET) to 15 November 2023, 17:00 (CET)

Clinical Trials Information System (CTIS): Walk-in clinic - January 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 January 2024, 16:00 (CET) to 24 January 2024, 17:00 (CET)

First version of the Union list of critical medicines agreed to help avoid potential shortages in the EU

EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 7: Submission of other post-authorisation data